Compare Cloudflare Inc (NET) vs TG Therapeutics Inc (TGTX) Price & Performance

Cloudflare (NET) trades at $314.30, up 1.26% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth, with Q2 2026 sales up 36% year-over-year to $696.1 million, and has beaten EPS estimates for three consecutive quarters. However, it remains unprofitable with a net income margin of -8.21% and carries a premium valuation with a P/S ratio of 42.99.

The investment case hinges on Cloudflare's leadership in cloud security and AI-driven demand, but high valuation and persistent losses pose risks. Analyst consensus is bullish with a $337.10 price target, though competitive pressures and execution challenges could impact growth.

TG Therapeutics (TGTX) trades at $49.66, up 1.02% on the day, with a bearish technical signal and recent earnings misses despite strong revenue growth. The company reported Q2 2026 revenue of $240 million and raised full-year BRIUMVI guidance to $950 million, but net income was impacted by manufacturing investments. Valuation ratios show a high P/E of 18.22 and EV/EBITDA of 56.26, while profitability metrics like ROE of 100.28% remain robust.

Outlook is mixed: strong product demand and raised revenue targets support growth, but earnings volatility and a bearish technical trend pose risks. Analyst consensus is bullish with an $63.75 price target, though legal investigations and competitive pressures require monitoring for stock investors.